| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5903171 | Metabolism | 2013 | 4 Pages |
Abstract
M2/ANXA5 seems an independent RPL risk factor in PCOS patients that progressively correlates with the number of first trimester pregnancies. From our pilot study in PCOS women it appears relevant to offer M2/ANXA5 diagnostic analysis to such patients with RPL complications, to possibly guide proper therapeutic decisions.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Nina Rogenhofer, Laura Engels, Nadja Bogdanova, Frank Tüttelmann, Christian J. Thaler, Arseni Markoff,